BAYER AG-REG (1BAYN.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:1BAYN - DE000BAY0017 - Common Stock
1BAYN.MI Key Statistics, Chart & Performance
The current stock price of 1BAYN.MI is 35.49 EUR. In the past month the price increased by 29.1%. In the past year, price increased by 78.97%.
1BAYN.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SNW.DE | SANOFI | 10.84 | 200.10B | ||
| 1SAN.MI | SANOFI | 10.75 | 198.47B | ||
| SAN.PA | SANOFI | 10.82 | 199.76B | ||
| MRK.DE | MERCK KGAA | 14.28 | 52.98B | ||
| UNC.DE | UCB SA | 37.51 | 46.84B | ||
| UCB.BR | UCB SA | 36.82 | 45.98B | ||
| BAYN.DE | BAYER AG-REG | 6.82 | 35.77B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 24.62 | 10.14B | ||
| IPN.PA | IPSEN | 11.62 | 10.00B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 100.72 | 9.32B | ||
| VIRP.PA | VIRBAC SA | 20.65 | 3.00B | ||
| DMP.DE | DERMAPHARM HOLDING SE | 18.19 | 2.11B |
Related stock screener links
About 1BAYN.MI
Company Profile
Bayer AG engages in the business of life science fields of healthcare and nutrition. The company is headquartered in Leverkusen, Nordrhein-Westfalen and currently employs 88,502 full-time employees. The firm's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.
Company Info
BAYER AG-REG
Kaiser-Wilhelm-Allee 1
Leverkusen NORDRHEIN-WESTFALEN DE
Employees: 90587
Phone: 49214301
BAYER AG-REG / 1BAYN.MI FAQ
What does 1BAYN do?
Bayer AG engages in the business of life science fields of healthcare and nutrition. The company is headquartered in Leverkusen, Nordrhein-Westfalen and currently employs 88,502 full-time employees. The firm's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.
What is the current price of 1BAYN stock?
The current stock price of 1BAYN.MI is 35.49 EUR. The price decreased by -1.13% in the last trading session.
What is the dividend status of BAYER AG-REG?
BAYER AG-REG (1BAYN.MI) has a dividend yield of 0.31%. The yearly dividend amount is currently 0.13.
How is the ChartMill rating for BAYER AG-REG?
1BAYN.MI has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Should I buy 1BAYN stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1BAYN.MI.
What is the market capitalization of 1BAYN stock?
BAYER AG-REG (1BAYN.MI) has a market capitalization of 34.87B EUR. This makes 1BAYN.MI a Large Cap stock.
What is the next earnings date for 1BAYN stock?
BAYER AG-REG (1BAYN.MI) will report earnings on 2026-02-25, after the market close.
1BAYN.MI Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to 1BAYN.MI. When comparing the yearly performance of all stocks, 1BAYN.MI is one of the better performing stocks in the market, outperforming 93.81% of all stocks.
1BAYN.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1BAYN.MI. Both the profitability and financial health of 1BAYN.MI have multiple concerns.
1BAYN.MI Financial Highlights
Over the last trailing twelve months 1BAYN.MI reported a non-GAAP Earnings per Share(EPS) of 5.34. The EPS decreased by -8.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| Debt/Equity | 1.11 |
1BAYN.MI Forecast & Estimates
28 analysts have analysed 1BAYN.MI and the average price target is 33.55 EUR. This implies a price decrease of -5.47% is expected in the next year compared to the current price of 35.49.
For the next year, analysts expect an EPS growth of -5.16% and a revenue growth -1.56% for 1BAYN.MI